Sorin takes Ovatio Implantable cardioverter defibrillators (ICDs) to Europe:
This article was originally published in Clinica
Sorin Group has launched in Europe what it claims are the world's smallest implantable cardioverter defibrillators (ICDs). The Ovatio line of devices, which comprise both a dual chamber and single chamber model, measure 29cc and are 11mm thin, said the Milan, Italy firm. The dual chamber model includes the firm's AAIsafeR pacing technology, which promotes natural heart activity by limiting unnecessary stimulation in the right ventricle, thereby preventing the onset and progression of heart failure.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.